全球消融技术市场：市场规模和占有率分析（依产品、应用和最终用户）、工业需求预测（截至 2030 年）

全球消融技术市场预计到2023年将实现收入53.132亿美元，2024年至2030年复合年增长率为9.0%。随着这一成长，市场规模预计到 2030 年将达到 96.729 亿美元。

这一发展是由心臟病、癌症、眼科、妇科和泌尿科等慢性疾病患者数量的快速增加所推动的。因此，对有效手术治疗的需求不断增加，对消融装置的需求也增加。

射频消融仪主导市场

2023 年，射频消融器细分市场占最大占有率，达到 25%。此外，预测期内复合年增长率预计为 9.2%。

随着 RFA 越来越多地用于治疗多种疾病，包括良性和肿瘤性肿瘤、慢性颈部和背部疼痛以及腿部慢性静脉缺陷，这个类别正在不断增长。

消融技术最常用于心血管治疗

就2023年的申请量而言，心血管类别占最大占有率。

消融技术广泛用于治疗心房颤动，并有助于破坏导致心律不整的不规则电讯号。

北美市场占最大占有率

2023年，北美地区是消融技术产业最大的市场。这是由于这项技术的发展以及对其许多治疗应用的瞭解不断增加。

预测期内，亚太地区将以 9.5% 的复合年增长率成长最快。这是由于有关微创方法的知识迅速增加、医疗保健系统的发展和经济成长。

本报告分析了全球消融技术市场，并提供了市场的基本结构和最新情况、主要促进和抑制因素以及全球、依地区和主要国家的市场规模前景（价值基础，2017-2030年） ），依产品、应用和最终用户划分的详细趋势、市场竞争的现状以及主要公司的概况。

目录

第一章 调查范围

第二章研究方法

第3章执行摘要

第四章 市场指标

第五章 产业展望

• 市场动态
  • 趋势
  • 促进因素
  • 抑制因素/课题
  • 促进/抑制因素影响分析
• 新型冠状病毒感染（COVID-19）的影响
• 波特五力分析

第六章 世界市场

• 概述
• 市场收入：依产品分类（2017-2030）
• 市场收入：依应用分类（2017-2030）
• 市场收入：依最终用户分类（2017-2030）
• 市场收入：依地区（2017-2030）

第七章 北美市场

• 概述
• 市场收入：依产品分类（2017-2030）
• 市场收入：依应用分类（2017-2030）
• 市场收入：依最终用户分类（2017-2030）
• 市场收入：依国家分类（2017-2030）

第八章欧洲市场

第九章亚太市场

第十章 拉丁美洲市场

第十一章 中东和非洲（MEA）市场

第十二章 美国市场

• 概述
• 市场收入：依产品分类（2017-2030）
• 市场收入：依应用分类（2017-2030）
• 市场收入：依最终用户分类（2017-2030）

第十三章 加拿大市场

第十四章 德国市场

第十五章 法国市场

第十六章 英国市场

第十七章 义大利市场

第十八章 西班牙市场

第十九章 日本市场

第20章 中国市场

第21章 印度市场

第22章澳洲市场

第23章 韩国市场

第24章 巴西市场

第25章 墨西哥市场

第26章 沙乌地阿拉伯市场

第27章南非市场

第28章 阿拉伯联合大公国（UAE）市场

第29章竞争格局

• 市场参与者及其提供的产品/服务的列表
• 主要企业竞争基准
• 主要公司的产品基准
• 近期策略发展状况

第三十章 公司简介

• Medtronic plc.
• Johnson & Johnson Services Inc.
• Abbott Laboratories
• Boston Scientific Corporation
• Olympus Corporation
• Stryker Corporation
• Smith & Nephew plc
• Varian Medical Systems Inc.
• CONMED Corporation
• AngioDynamics Inc.

第31章附录

The ablation technology market worldwide achieved revenue of USD 5,313.2 million in

2023, and it is anticipated to grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2030. This growth is expected to lead to a market size of USD 9,672.9 million by the year 2030.

The development can be credited to the surge in the count of cases of chronic diseases, like heart diseases, cancer, and ophthalmologic, gynecological, and urological diseases. As a result, there is an increased need for efficient surgical treatments, leading to higher demand for ablation devices.

Market Trends/Drivers

The increasing awareness regarding ablation procedures, growing healthcare spending, growing count of cancer cases, less cost of this procedure, and technical enhancements in related devices are the key reasons boosting the industry.

The growing count of hospitals and ambulatory operation centers is projected to fuel the development of the industry.

The growth in the ageing populace and surge in the need for minimally invasive procedures, credited to their benefits over the conventional, open procedures, will boost the product need.

Furthermore, minimally invasive methods provide precise results and are inexpensive for both care patients and providers. Moreover, the range of these procedures obtainable for different parts of the body, like brain surgeries, adrenalectomies, hiatal hernia repairs, colectomies, and nephrectomies, has made them enormously popular.

The Market Is Dominated by Radiofrequency Ablators

The radiofrequency ablators segment held the largest share, 25%, in 2023.

It is projected to experience a CAGR of 9.2% during the projection period.

This category is growing because of the growing utilization of RFA for several treatments like benign and oncogenic tumors, chronic neck and back pain, chronic venous deficiency in the legs, and more.

RFA is also used for treating atrial fibrillation, an irregular heartbeat condition.

FDA approvals for advanced radiofrequency ablators are expected to further boost the market.

Example: RF Medical Co. Ltd. received FDA clearance in December 2022 for its MYGEN M-3004 generator and MYOBLATE RFA system for use in the U.S.

Laser ablation also grips a substantial share in the industry, because of the research being done on this technology. In their January 2023 study, researchers showed that the co-administration of compression therapy with endovenous laser ablation positively impacted the rate of healing of venous ulcers and reduced the likelihood of recurrence.

Ablation Technology Founds Its Highest Usage in Cardiovascular Treatments

The cardiovascular category held the largest share in 2023 in terms of application.

Ablation technology is extensively used in treating atrial fibrillation, aiding in disrupting the irregular electrical signals responsible for irregular heartbeats.

Each cell in the myocardium generates its own signal for heartbeat, and when synchronization fails among cells, arrhythmia (irregular heartbeat) can result.

Ablation procedures are utilized to block the aberrant electric signals causing arrhythmias, restoring normal heart rhythm.

North America Held the Largest Share in the Market

In 2023, the North American region was the largest customer in the ablation technology industry, because of the growth in the technology and increasing knowledge about its applications in many treatments.

The surge in the count of patients who are suffering from chronic diseases mainly cancer is contributing to the development of the industry. Already, cancer is one of the top 10 foremost causes of demise in the nation. Its death rate is projected to surge to approximately 3 million by the end of 2040. also, approximately 37.3 million individuals in the nation were found to have diabetes, and about 96 million grownups were found to have pre-diabetes.

During the projection period, the Asia-Pacific region will be the fastest-rising ablation tech industry, with a CAGR of 9.5%. This can be credited to the surging knowledge regarding minimally invasive methods, growing healthcare systems, and rising economies.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by product
  • 1.4.2. Market size breakdown, by application
  • 1.4.3. Market size breakdown, by end user
  • 1.4.4. Market size breakdown, by region
  • 1.4.5. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Product (2017-2030)
• 6.3. Market Revenue, by Application (2017-2030)
• 6.4. Market Revenue, by End User (2017-2030)
• 6.5. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Product (2017-2030)
• 7.3. Market Revenue, by Application (2017-2030)
• 7.4. Market Revenue, by End User (2017-2030)
• 7.5. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Product (2017-2030)
• 8.3. Market Revenue, by Application (2017-2030)
• 8.4. Market Revenue, by End User (2017-2030)
• 8.5. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Product (2017-2030)
• 9.3. Market Revenue, by Application (2017-2030)
• 9.4. Market Revenue, by End User (2017-2030)
• 9.5. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Product (2017-2030)
• 10.3. Market Revenue, by Application (2017-2030)
• 10.4. Market Revenue, by End User (2017-2030)
• 10.5. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Product (2017-2030)
• 11.3. Market Revenue, by Application (2017-2030)
• 11.4. Market Revenue, by End User (2017-2030)
• 11.5. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Product (2017-2030)
• 12.3. Market Revenue, by Application (2017-2030)
• 12.4. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Product (2017-2030)
• 13.3. Market Revenue, by Application (2017-2030)
• 13.4. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Product (2017-2030)
• 14.3. Market Revenue, by Application (2017-2030)
• 14.4. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Product (2017-2030)
• 15.3. Market Revenue, by Application (2017-2030)
• 15.4. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Product (2017-2030)
• 16.3. Market Revenue, by Application (2017-2030)
• 16.4. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Product (2017-2030)
• 17.3. Market Revenue, by Application (2017-2030)
• 17.4. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Product (2017-2030)
• 18.3. Market Revenue, by Application (2017-2030)
• 18.4. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Product (2017-2030)
• 19.3. Market Revenue, by Application (2017-2030)
• 19.4. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Product (2017-2030)
• 20.3. Market Revenue, by Application (2017-2030)
• 20.4. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Product (2017-2030)
• 21.3. Market Revenue, by Application (2017-2030)
• 21.4. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Product (2017-2030)
• 22.3. Market Revenue, by Application (2017-2030)
• 22.4. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Product (2017-2030)
• 23.3. Market Revenue, by Application (2017-2030)
• 23.4. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Product (2017-2030)
• 24.3. Market Revenue, by Application (2017-2030)
• 24.4. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Product (2017-2030)
• 25.3. Market Revenue, by Application (2017-2030)
• 25.4. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Product (2017-2030)
• 26.3. Market Revenue, by Application (2017-2030)
• 26.4. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Product (2017-2030)
• 27.3. Market Revenue, by Application (2017-2030)
• 27.4. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Product (2017-2030)
• 28.3. Market Revenue, by Application (2017-2030)
• 28.4. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Medtronic plc.
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Johnson & Johnson Services Inc.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Abbott Laboratories
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. Boston Scientific Corporation
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Olympus Corporation
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Stryker Corporation
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Smith & Nephew plc
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Varian Medical Systems Inc.
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. CONMED Corporation
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary
• 30.10. AngioDynamics Inc.
  • 30.10.1. Business overview
  • 30.10.2. Product and service offerings
  • 30.10.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports